Ma L, Zhang Y, Liu P, Li S, Li Y, Ji T, Zhang L, Chhetri J K, Li Y
Lina Ma, M.D., Ph.D., Department of Geriatrics, Xuanwu Hospital, Capital Medical University, National Research Center for Geriatric Medicine, E-mail address:
J Nutr Health Aging. 2021;25(2):271-277. doi: 10.1007/s12603-020-1468-3.
To determine the association between plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) and intrinsic capacity in an older population.
We recruited 283 participants aged 60-97 years (mean 77.42±4.08 years). Intrinsic capacity was assessed with the World Health Organization Integrated Care for Older People (ICOPE) screening tool including six domains: cognition, locomotion, vitality, hearing, vision, and psychology. Multimorbidity, polypharmacy, gait speed, physical activity, lifestyles, and chronic inflammation were assessed. We used multivariate logistic regression and the Spearman's correlation to assess the association between plasma NT-proBNP and intrinsic capacity.
The average intrinsic capacity score was 4.53±1.34. The percentage of decreased intrinsic capacity was 75.3%. Participants with decreased intrinsic capacity were older, with more cardiovascular and cerebrovascular diseases and polypharmacy, and had lower gait speed and higher C-reactive protein. Plasma NT-proBNP was significantly higher in the decreased intrinsic capacity group (128.0[56.8-280.8] pg/mL vs. 72.6[39.7-120.0] pg/mL, p<0.001). Multivariate logistic regression analysis revealed that NT-proBNP was the only independent risk factor for decreased intrinsic capacity among multiple covariates (odds ratio=1.005, p=0.038). Elevated NT-proBNP levels were associated with abnormal locomotion, hearing, vision, and psychology domains. Additionally, NT-proBNP levels were inversely correlated with the intrinsic capacity score adjusted for both age and coronary artery disease (r=-0.371, p< 0.001).
Elevated NT-proBNP levels were associated with decreased intrinsic capacity in older persons, independent of age, multimorbidity, polypharmacy, and chronic inflammation. Further longitudinal studies are required to explore the predictive role of NT-proBNP on declines in intrinsic capacity.
确定老年人群血浆N末端B型利钠肽原(NT-proBNP)与内在能力之间的关联。
我们招募了283名年龄在60 - 97岁(平均77.42±4.08岁)的参与者。使用世界卫生组织老年人综合照护(ICOPE)筛查工具评估内在能力,该工具包括六个领域:认知、运动、活力、听力、视力和心理。评估了多种疾病、多种药物治疗、步速、身体活动、生活方式和慢性炎症。我们使用多变量逻辑回归和Spearman相关性分析来评估血浆NT-proBNP与内在能力之间的关联。
内在能力平均得分为4.53±1.34。内在能力下降的比例为75.3%。内在能力下降的参与者年龄更大,患有更多的心脑血管疾病且使用多种药物治疗,步速更低且C反应蛋白更高。内在能力下降组的血浆NT-proBNP显著更高(128.0[56.8 - 280.8] pg/mL对72.6[39.7 - 120.0] pg/mL,p<0.001)。多变量逻辑回归分析显示,在多个协变量中,NT-proBNP是内在能力下降的唯一独立危险因素(比值比 = 1.005,p = 0.038)。NT-proBNP水平升高与运动、听力、视力和心理领域异常相关。此外,NT-proBNP水平与经年龄和冠状动脉疾病校正后的内在能力得分呈负相关(r = -0.371,p<0.001)。
NT-proBNP水平升高与老年人内在能力下降相关,独立于年龄、多种疾病、多种药物治疗和慢性炎症。需要进一步的纵向研究来探讨NT-proBNP对内在能力下降的预测作用。